 |
||
|---|---|---|
| 【ProductName】 |
PCK1 Antibody Blocking Peptide |
|
| 【Cat NO.】 |
K109862P-Ag |
|
| 【Source】 |
Synthetic |
|
| 【Storage】 |
Store at -20℃，2 years.Avoid freeze/thaw cycles. |
|
| 【Appearance】 |
Lyophilized powder |
|
| 【Swiss Prot】 |
P35558 |
|
| 【Gene ID】 |
5105 |
|
| 【Application】 |
Blocking Peptide of K109862P Antibody |
|
| 【Purification】 |
HPLC |
|
| 【Activity】 |
Not tested |
|
| 【Note】 |
Please allow the product to equilibrate to room temperature in a dry environment before opening the packaging. |
|
|
||
Background：
Regulates cataplerosis and anaplerosis， the processes that control the levels of metabolic intermediates in the citric acid cycle. At low glucose levels， it catalyzes the cataplerotic conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP)， the rate-limiting step in the metabolic pathway that produces glucose from lactate and other precursors derived from the citric acid cycle. At high glucose levels， it catalyzes the anaplerotic conversion of phosphoenolpyruvate to oxaloacetate.